Resverlogix (TSE:RVX) Hits New 52-Week Low at $0.05

Resverlogix Corp. (TSE:RVXGet Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.05 and last traded at C$0.05, with a volume of 2300 shares traded. The stock had previously closed at C$0.05.

Resverlogix Stock Up 10.0 %

The stock has a 50-day simple moving average of C$0.06 and a 200-day simple moving average of C$0.06. The firm has a market capitalization of C$15.12 million, a PE ratio of -0.63 and a beta of 0.69.

Resverlogix (TSE:RVXGet Free Report) last released its earnings results on Monday, April 1st. The biotechnology company reported C($0.01) earnings per share (EPS) for the quarter. Equities analysts forecast that Resverlogix Corp. will post -0.22 earnings per share for the current fiscal year.

Resverlogix Company Profile

(Get Free Report)

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.

See Also

Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.